{
    "2021-07-06": [
        [
            {
                "time": "",
                "original_text": "医药行业：创新药和CXO行业加速结构化进程",
                "features": {
                    "keywords": [
                        "创新药",
                        "CXO",
                        "结构化进程"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业双周报",
                "features": {
                    "keywords": [
                        "医药生物",
                        "双周报"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业(300558.SZ)股东贝成投资累计减持157.56万股 减持股份数量",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "贝成投资",
                        "减持",
                        "股份数量"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业：股东股份减持的进展公告 减持股份数量",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "股东",
                        "减持",
                        "进展公告"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业(300558.SZ)：贝成投资减持期届满 累计减持0.38%股份 减持股份数量",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "贝成投资",
                        "减持期届满",
                        "累计减持"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业：股东贝成投资减持约158万股，减持计划已届满 拟减持股份",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "贝成投资",
                        "减持计划",
                        "届满"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业：贝成投资减持0.38%公司股份 减持股份数量",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "贝成投资",
                        "减持",
                        "股份数量"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}